Financial News
Latest News about fda
Recent news which mentions fda
From Benzinga
From Benzinga
Psyched: New Evidence Shows Psilocybin As Anxiety Therapy, Open-Source Learning For Therapists, Enveric's Licensing Deals And More
March 04, 2024
From Benzinga
Why Quoin Pharmaceutical Stock Is Soaring
March 04, 2024
From Benzinga
Kratom, CBD, Marijuana: Regulatory Update, Get Tuned In Under 2 Minutes
February 29, 2024
From Benzinga
FDA Grants Review Date For Applied Therapeutics' First Commercial Product For Rare Metabolic Disorder
February 28, 2024
From Benzinga
Regulatory Setback For Minerva Neurosciences' Schizophrenia Treatment Candidate, FDA Asks For More Data
February 27, 2024
From Benzinga
New York Attorney General Urges FDA Action On Widely Used Asthma Drug's Concerns Over Pediatric Safety
February 26, 2024
From Benzinga
Why Is Generic Drugs Player Teva Pharma Stock Trading Higher Today?
February 26, 2024
From Benzinga
Do Not Use Smartwatches, Rings That Claim To Measure Blood Sugar Without Needles, FDA Says
February 22, 2024
From Benzinga
United Therapeutics' Challenges FDA Over Liquidia's Drug Approval Process, Clocks Strong Q4 Earnings
February 21, 2024
From Benzinga
FDA Approves Johnson & Johnson's Reduced Tecvayli Dosing In Pretreated Multiple Myeloma Patients
February 21, 2024
From Benzinga
FDA Gathers Public Social Media Data To Better Understand Cannabis Users As Part Of Its Effort Toward Rescheduling Marijuana
February 20, 2024
From Benzinga
ARS Pharma Readies Data In Response To FDA's Rejection For Its EpiPen Alternative For Severe Allergic Reactions
February 20, 2024
From Benzinga
Why Is Inflammatory Disease/Oncology-Focused RAPT Therapeutics Shares Tumbling Today?
February 20, 2024
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.